Company / Gross Profit per Share
TREACE MEDICAL CONCEPTS, INC. Gross Profit per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$2.50
FY2025
5-year range
$0.83 / $2.50
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has increased for 3 consecutive years, from $0.83 in FY2022 to $2.50 in FY2025.
Based on SEC 10-K filings.
2.50 in FY2025 with a 3-year CAGR of +44.4%.
Improved from $1.39 to $2.50 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +44.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s gross profit per share has grown for 3 consecutive years.
- In FY2025, gross profit per share increased 18.7% year-over-year.
- Lowest gross profit per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.50 | +18.7% |
| FY2024 | $2.10 | +51.0% |
| FY2023 | $1.39 | +68.2% |
| FY2022 | $0.83 | -3.8% |
| FY2021 | $0.86 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026